Skip to content
OpenCapital
Get started

Ardelyx ARDX Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number at other companies

Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
——

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%—
Net margin-13.6%—
FCF margin-40.9%—

Returns & leverage

See full
Return on equity-39.5%—
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.

The official record: Ardelyx’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number?
Ardelyx (ARDX) reported share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number of $28.98M in Q4 2025.
How has Ardelyx's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number changed year-over-year?
Ardelyx's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number increased by 3.2% year-over-year, from $28.09M to $28.98M.
What is the long-term trend for Ardelyx's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number?
Over 4 years (2021 to 2025), Ardelyx's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number has grown at a 29.1% compound annual growth rate (CAGR), from $10.42M to $28.98M.